Skip to main content
Swing Capital

Gaudium IVF and Women Health Ltd

NSE: GAUDIUMIVF BSE: 544709

Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India.[1]

₹104
52W: ₹69.2 — ₹133
PE 41 · Book ₹0 · +0% vs book
Market Cap₹756 Cr
Stock P/E41Price to Earnings
ROCE47.8%Return on Capital
ROE51.6%Return on Equity
Div. Yield0%Face Value ₹5

Strengths

  • +Company has a good return on equity (ROE) track record: 3 Years ROE 50.0%

Weaknesses

  • −Debtor days have increased from 87.3 to 146 days.

Shareholding Pattern

Promoters71.29%
FIIs6.7%
DIIs2.63%
Public19.39%
CategoryMar 2026
Promoters71.29%
FIIs6.7%
DIIs2.63%
Public19.39%

Financial Statements

MetricDec 2024Sep 2025Dec 2025
Sales13.9522.9514.19
Expenses8.379.678.36
Operating Profit5.5813.285.83
OPM %40%57.86%41.09%
Net Profit3.359.033.18
EPS ₹0.551.470.52

AI Insights

Revenue Trend

Mar 2025 revenue at ₹59Cr, up 28.3% YoY. OPM at 48%.

Debt Position

Borrowings at ₹21Cr. Debt-to-equity ratio: 1.40x. High leverage — monitor closely.

Capex Cycle

CWIP at ₹7Cr (39% of fixed assets). Significant capex underway — growth runway building.

Margin & Efficiency

ROCE improving from 0% (Mar 2023) to 48% (Mar 2025). Working capital days: 46.

Valuation

PE 41x with 47.8% ROCE. Price is N/A% above book value of ₹0. Dividend yield: 0%.

Recent Announcements